These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15911470)

  • 21. Research ethics across the 49th parallel: the potential value of pilot testing "equivalent protections" in Canadian research institutions.
    Lavery JV; McDonald M; Meslin EM
    Health Law Rev; 2005; 13(2-3):86-96. PubMed ID: 16459420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What do people at risk for Alzheimer disease think about surrogate consent for research?
    Kim SY; Kim HM; McCallum C; Tariot PN
    Neurology; 2005 Nov; 65(9):1395-401. PubMed ID: 16275826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disclosure of the right of research participants to receive research results: an analysis of consent forms in the Children's Oncology Group.
    Fernandez CV; Kodish E; Taweel S; Shurin S; Weijer C;
    Cancer; 2003 Jun; 97(11):2904-9. PubMed ID: 12767106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Waste not, want not: cognitive impairment should not preclude research participation.
    Hougham GW
    Am J Bioeth; 2005; 5(1):36-7; author reply W15-8. PubMed ID: 16036655
    [No Abstract]   [Full Text] [Related]  

  • 25. Paying research subjects: historical considerations.
    Hutt LE
    Health Law Rev; 2003; 12(1):16-21. PubMed ID: 15742492
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical trials finance and operations.
    O'Brien JA
    J Med Pract Manage; 2007; 22(6):369-71. PubMed ID: 17612316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gather ye shibboleths while ye may.
    Fost N
    Am J Bioeth; 2005; 5(5):14-5. PubMed ID: 16179297
    [No Abstract]   [Full Text] [Related]  

  • 28. Proposing modesty for informed consent.
    Burgess MM
    Soc Sci Med; 2007 Dec; 65(11):2284-95. PubMed ID: 17884264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Financial remuneration for clinical and behavioral research participation: ethical and practical considerations.
    Permuth-Wey J; Borenstein AR
    Ann Epidemiol; 2009 Apr; 19(4):280-5. PubMed ID: 19230712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ethics committees in USA--background and development. Responsible conductors of clinical trials required for risk minimization].
    Lund LH
    Lakartidningen; 2008 Jan 9-15; 105(1-2):42-4. PubMed ID: 18293746
    [No Abstract]   [Full Text] [Related]  

  • 31. Some questionable premises about research ethics.
    Macklin R
    Am J Bioeth; 2005; 5(1):29-31; author reply W15-8. PubMed ID: 16036652
    [No Abstract]   [Full Text] [Related]  

  • 32. Increasing the amount of payment to research subjects.
    Resnik DB
    J Med Ethics; 2008 Sep; 34(9):e14. PubMed ID: 18757614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reflections on 'Rethinking research ethics'.
    Levine RJ
    Am J Bioeth; 2005; 5(1):1-3; author reply W15-8. PubMed ID: 16036649
    [No Abstract]   [Full Text] [Related]  

  • 34. Financial help for research subjects enrolled in "approved clinical studies".
    Maloney DM
    Hum Res Rep; 2001 Apr; 16(4):9. PubMed ID: 11883457
    [No Abstract]   [Full Text] [Related]  

  • 35. Unconditional compensation: reducing the costs of disagreement about compensation for research subjects.
    Sofaer N; Jafarey A; Lei RP; Zhang X; Wikler D
    East Mediterr Health J; 2007; 13(1):6-16. PubMed ID: 17546900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Who's paying for new drugs?
    Oldham RK
    Nature; 1988 Apr; 332(6167):795. PubMed ID: 3282177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimal-risk waiver of informed consent and exception from informed consent (Final Rule) studies at institutional review boards nationwide.
    Ernst AA; Weiss SJ; Nick TG; Iserson K; Biros MH
    Acad Emerg Med; 2005 Nov; 12(11):1134-7. PubMed ID: 16264084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Informed consent, capitation, and conflicts of interest in clinical trials: views from the field.
    Angelos P; Murphy TF; Sampson H; Hollings DD; Kshettry V
    Surgery; 2006 Nov; 140(5):740-8. PubMed ID: 17084716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caregivers as subjects of clinical drug trials: a review of human subjects protection practices in published studies of Alzheimer's disease pharmacotherapies.
    Lingler JH; Parker LS; DeKosky ST; Schulz R
    IRB; 2006; 28(3):11-8. PubMed ID: 17036439
    [No Abstract]   [Full Text] [Related]  

  • 40. Guinea-pigging: healthy human subjects for drug safety trials are in demand. But is it a living?
    Elliott C
    New Yorker; 2008 Jan; ():36-41. PubMed ID: 18265451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.